Immunomedics prices public offering

Shares of Immunomedics (IMMU -20.4%) are down big on a 2x surge in volume after the firm announced its secondary offering of 9M shares of common stock at $3.35. Yesterday's close was $4.14.

Underwriters over-allotment is 1.35M shares.

Proceeds will fund its clinical trials.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs